Patents by Inventor Annette Bettina GALLER

Annette Bettina GALLER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210317201
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: June 23, 2021
    Publication date: October 14, 2021
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Gerald Henry NABOZNY, Annette Bettina GALLER, Patrick GARIDEL, William Troy LOGING, Steven John PADULA, Torsten SCHULTZ-FADEMRECHT, Elaine Ee-Ling WANG
  • Patent number: 11078265
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Grant
    Filed: April 25, 2013
    Date of Patent: August 3, 2021
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Gerald Henry Nabozny, Annette Bettina Galler, Patrick Garidel, William Troy Loging, Steven John Padula, Torsten Schultz-Fademrecht, Elaine Ee-Ling Wang
  • Publication number: 20200308271
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: December 21, 2019
    Publication date: October 1, 2020
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth Flack, Annette Bettina Galler, Bojan Lalovic, Kaori Maino, Steven John Padula, Paul Scholl, Koji Sha, Sudha Visvanathan
  • Publication number: 20200299378
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: December 13, 2019
    Publication date: September 24, 2020
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Wulf Otto BOECHER, Annette Bettina GALLER, Bojan LALOVIC, Sudha VISVANATHAN
  • Publication number: 20180105588
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: October 11, 2017
    Publication date: April 19, 2018
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick Baum, Wulf Otto Boecher, Annette Bettina Galler, Bojan Lalovic, Sudha Visvanathan
  • Publication number: 20170298126
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis or psoriatic arthritis, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: April 13, 2017
    Publication date: October 19, 2017
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Patrick BAUM, Mary Ruth FLACK, Annette Bettina GALLER, Bojan LALOVIC, Kaori MAINO, Steven John PADULA, Paul SCHOLL, Koji SHA, Sudha VISVANATHAN
  • Publication number: 20170081402
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as Crohn's Disease, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: September 15, 2016
    Publication date: March 23, 2017
    Inventors: Wulf Otto BOECHER, Annette Bettina GALLER, Bojan LALOVIC, Steven John PADULA, Paul SCHOLL, Sudha VISVANATHAN
  • Publication number: 20160222102
    Abstract: This invention generally relates to methods for the treatment of IL-23 related diseases, in particular inflammatory diseases, such as psoriasis, psoriatic arthritis or axial (spinal) spondyloarthritis (ax-SpA), including ankylosing spondylitis and non-radiographic ax-SpA, utilizing anti-IL-23A antibodies.
    Type: Application
    Filed: February 2, 2016
    Publication date: August 4, 2016
    Inventors: Matthias ARNDT, Stella ASLANYAN, Mary Ruth FLACK, Annette Bettina GALLER, Bojan LALOVIC, Steven John PADULA, Paul Russell SCHOLL
  • Publication number: 20140178401
    Abstract: The present invention relates to anti-IL-23p19 binding compounds, in particular new humanized anti-IL-23p19 antibodies, pharmaceutical compositions and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: April 25, 2013
    Publication date: June 26, 2014
    Applicant: BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    Inventors: Gerald Henry NABOZNY, Annette Bettina GALLER, Patrick GARIDEL, William Troy LOGING, Steven John PADULA, Torsten SCHULTZ-FADEMRECHT, Elaine Ee-Ling WANG